甾醇调节元件结合蛋白
细胞生物学
合成代谢
巨噬细胞
转录因子
生物化学
化学
生物
脂质代谢
脂肪生成
体外
基因
作者
Guillaume Bidault,Sam Virtue,Kasparas Petkevicius,Helen E. Jolin,Aurélien Dugourd,Anne-Claire Guénantin,Jennifer Leggat,Betania Mahler‐Araujo,Brian Lam,Marcella Ma,Martin Dale,Stefania Carobbio,Arthur Kaser,Padraic G. Fallon,Julio Sáez-Rodríguez,Andrew N. J. McKenzie,Antonio Vidal‐Puig
标识
DOI:10.1038/s42255-021-00440-5
摘要
Macrophages exhibit a spectrum of activation states ranging from classical to alternative activation1. Alternatively, activated macrophages are involved in diverse pathophysiological processes such as confining tissue parasites2, improving insulin sensitivity3 or promoting an immune-tolerant microenvironment that facilitates tumour growth and metastasis4. Recently, the metabolic regulation of macrophage function has come into focus as both the classical and alternative activation programmes require specific regulated metabolic reprogramming5. While most of the studies regarding immunometabolism have focussed on the catabolic pathways activated to provide energy, little is known about the anabolic pathways mediating macrophage alternative activation. In this study, we show that the anabolic transcription factor sterol regulatory element binding protein 1 (SREBP1) is activated in response to the canonical T helper 2 cell cytokine interleukin-4 to trigger the de novo lipogenesis (DNL) programme, as a necessary step for macrophage alternative activation. Mechanistically, DNL consumes NADPH, partitioning it away from cellular antioxidant defences and raising reactive oxygen species levels. Reactive oxygen species serves as a second messenger, signalling sufficient DNL, and promoting macrophage alternative activation. The pathophysiological relevance of this mechanism is validated by showing that SREBP1/DNL is essential for macrophage alternative activation in vivo in a helminth infection model.
科研通智能强力驱动
Strongly Powered by AbleSci AI